4D·

Velo Plus 2025 -> 2033

Velo Plus $BATS (+1.09%) has achieved a ~12% share of the Modern Oral US market within a few months. This is expected to grow to over 50 billion dollars in the US by 2033, which corresponds to sales of 6 billion and profits of 4-5 billion, assuming the market share remains the same.

10
6 Comments

That means nicotine pouches, right? That means Zyn has approx. 65%, On! approx. 12% and Velo also 12%, right?
1
profile image
@MrCumEx As I understand it, Velo Plus alone has 12%. Altria only gives a share of the entire Oral segment of about 9% at On!
1
@TaxesAreTheft Thank you. Everyone is making a state secret out of it :(
profile image
@MrCumEx yes, BAT usually only issues volume shares, value shares only if they want to. Altria always takes the "wrong" sector with total Oral, if modern Oral is actually particularly interesting, then they say nicotine pouch segment with 17% share (which I don't believe, or rather that can't match the growth if Zyn has always grown faster than the overall category, Velo Plus has triple-digit growth and On! is at >20% growth), nobody knows whether that's value or volume anyway. And Philip Morris is also very particular because they only use their own data.
1
@TaxesAreTheft It's really funny. Everyone uses their own figures and in the end you know almost nothing. Unfortunately, everyone turns it into a state secret :-( It would be really interesting to find out in concrete terms...
1
profile image
@MrCumEx NielsenIQ always has quite good figures.
1
Join the conversation